225 related articles for article (PubMed ID: 26505091)
1. The identification of hypoxia biomarkers from exhaled breath under normobaric conditions.
Harshman SW; Geier BA; Fan M; Rinehardt S; Watts BS; Drummond LA; Preti G; Phillips JB; Ott DK; Grigsby CC
J Breath Res; 2015 Oct; 9(4):047103. PubMed ID: 26505091
[TBL] [Abstract][Full Text] [Related]
2. Exhaled isoprene for monitoring recovery from acute hypoxic stress.
Harshman SW; Geier BA; Qualley AV; Drummond LA; Flory LE; Fan M; Pitsch RL; Grigsby CC; Phillips JB; Martin JA
J Breath Res; 2017 Nov; 11(4):047111. PubMed ID: 29018179
[TBL] [Abstract][Full Text] [Related]
3. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study.
King J; Mochalski P; Kupferthaler A; Unterkofler K; Koc H; Filipiak W; Teschl S; Hinterhuber H; Amann A
Physiol Meas; 2010 Sep; 31(9):1169-84. PubMed ID: 20664160
[TBL] [Abstract][Full Text] [Related]
4. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
[TBL] [Abstract][Full Text] [Related]
5. Quantifying exhaled acetone and isoprene through solid phase microextraction and gas chromatography-mass spectrometry.
Schulz E; Woollam M; Vashistha S; Agarwal M
Anal Chim Acta; 2024 May; 1301():342468. PubMed ID: 38553125
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of breath VOCs and electrical impedance tomography under pulmonary recruitment in mechanically ventilated patients.
Brock B; Kamysek S; Silz J; Trefz P; Schubert JK; Miekisch W
J Breath Res; 2017 Jan; 11(1):016005. PubMed ID: 28068288
[TBL] [Abstract][Full Text] [Related]
7. Atmospheric pressure chemical ionization mass spectrometry of pyridine and isoprene: potential breath exposure and disease biomarkers.
Kapishon V; Koyanagi GK; Blagojevic V; Bohme DK
J Breath Res; 2013 Jun; 7(2):026005. PubMed ID: 23579200
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study.
Pabst F; Miekisch W; Fuchs P; Kischkel S; Schubert JK
J Cardiothorac Surg; 2007 Sep; 2():37. PubMed ID: 17877828
[TBL] [Abstract][Full Text] [Related]
9. FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests.
Sukul P; Schubert JK; Oertel P; Kamysek S; Taunk K; Trefz P; Miekisch W
Sci Rep; 2016 Jun; 6():28029. PubMed ID: 27311826
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
11. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
[TBL] [Abstract][Full Text] [Related]
12. Can volatile compounds in exhaled breath be used to monitor control in diabetes mellitus?
Smith D; Spaněl P; Fryer AA; Hanna F; Ferns GA
J Breath Res; 2011 Jun; 5(2):022001. PubMed ID: 21512208
[TBL] [Abstract][Full Text] [Related]
13. Detection of volatile organic compounds indicative of human presence in the air.
Kwak J; Geier BA; Fan M; Gogate SA; Rinehardt SA; Watts BS; Grigsby CC; Ott DK
J Sep Sci; 2015 Jul; 38(14):2463-9. PubMed ID: 25944350
[TBL] [Abstract][Full Text] [Related]
14. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease.
Meinardi S; Jin KB; Barletta B; Blake DR; Vaziri ND
Biochim Biophys Acta; 2013 Mar; 1830(3):2531-7. PubMed ID: 23274524
[TBL] [Abstract][Full Text] [Related]
16. Physiological modeling of isoprene dynamics in exhaled breath.
King J; Koc H; Unterkofler K; Mochalski P; Kupferthaler A; Teschl G; Teschl S; Hinterhuber H; Amann A
J Theor Biol; 2010 Dec; 267(4):626-37. PubMed ID: 20869370
[TBL] [Abstract][Full Text] [Related]
17. Towards the determination of isoprene in human breath using substrate-integrated hollow waveguide mid-infrared sensors.
Perez-Guaita D; Kokoric V; Wilk A; Garrigues S; Mizaikoff B
J Breath Res; 2014 Jun; 8(2):026003. PubMed ID: 24848160
[TBL] [Abstract][Full Text] [Related]
18. Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview.
Salerno-Kennedy R; Cashman KD
Wien Klin Wochenschr; 2005 Mar; 117(5-6):180-6. PubMed ID: 15875756
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence the volatile organic compound content in human breath.
Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
[TBL] [Abstract][Full Text] [Related]
20. Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method.
Grabowska-Polanowska B; Faber J; Skowron M; Miarka P; Pietrzycka A; Sliwka I; Amann A
J Chromatogr A; 2013 Aug; 1301():179-89. PubMed ID: 23764192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
